Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02890602
What this trial is testing

Erythropoietin for Management of Anemia Caused by Chemotherapy

Who this might be right for
Diffuse Large B-cell Lymphoma
Kosin University Gospel Hospital 53
Not applicableActive Not RecruitingNCT07310745
What this trial is testing

Low Dose Radiotherapy in Primary Indolent Cutaneous B-cell Lymphoma

Who this might be right for
Primary Indolent Cutaneous B-cell Lymphoma
Azienda USL Reggio Emilia - IRCCS 52
Testing effectiveness (Phase 2)Study completedNCT02853370
What this trial is testing

Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma

Who this might be right for
Marginal Zone B-cell Lymphoma
International Extranodal Lymphoma Study Group (IELSG) 78
Early research (Phase 1)Study completedNCT00944905
What this trial is testing

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Who this might be right for
Renal Cell CarcinomaNon-hodgkin's Lymphoma
Bristol-Myers Squibb 46
Large-scale testing (Phase 3)Looking for participantsNCT07011056
What this trial is testing

A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Recurrent and Refractory Diffuse Large B-cell Lymphoma
Chengdu Zenitar Biomedical Technology Co., Ltd 390
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07192237
What this trial is testing

Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Phase 2 StudyBlinatumomabAcute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 40
Early research (Phase 1)Ended earlyNCT02588456
What this trial is testing

Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
University of Pennsylvania 5
Testing effectiveness (Phase 2)Ended earlyNCT00792831
What this trial is testing

Phase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Italfarmaco 3
Post-approval studies (Phase 4)Not Yet RecruitingNCT06956092
What this trial is testing

Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

Who this might be right for
B Cell Lymphoma (BCL)
Zhengzhou University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05535244
What this trial is testing

A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hoffmann-La Roche 90
Large-scale testing (Phase 3)UnknownNCT03391739
What this trial is testing

CART-19 Cells For R/R B-ALL

Who this might be right for
Relapsed/Refractory B-cell ALL
Fujian Medical University 20
Not applicableLooking for participantsNCT06450067
What this trial is testing

Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd. 200
Not applicableNot Yet RecruitingNCT07463781
What this trial is testing

Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)High Grade B Cell LymphomaPrimary Mediastinal B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS 100
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableLooking for participantsNCT06355739
What this trial is testing

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

Who this might be right for
B Lymphocytic LeukemiaB Lymphoblastic Lymphoma
Zhu Xiaofan 60
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Testing effectiveness (Phase 2)Ended earlyNCT04430530
What this trial is testing

4SCAR-T Therapy Post CD19-targeted Immunotherapy

Who this might be right for
CD19 Negative B-cell Malignancies
Shenzhen Geno-Immune Medical Institute 100
Early research (Phase 1)Study completedNCT00347971
What this trial is testing

Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
ZymoGenetics 23
Testing effectiveness (Phase 2)Study completedNCT04078386
What this trial is testing

TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren's Syndrome

Who this might be right for
Primary Sjögren's Syndrome
RemeGen Co., Ltd. 42
Large-scale testing (Phase 3)Active Not RecruitingNCT06956170
What this trial is testing

All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 21
Next Page